|Page (1) of 1 - 10/05/17||email article||print page|
Global CAR-T r/r CLL Market, 2017-2030(October 05, 2017)
Dublin, Oct. 05, 2017 (GLOBE NEWSWIRE) -- The "CAR-T r/r CLL Global Market Forecast" report has been added to Research and Markets' offering.
Novel immune-therapeutic approaches in development for CLL include monoclonal antibodies, bi-specific antibodies, anti-PD1/PDL-1 checkpoint inhibitors, and the CAR-T cell therapies including JCAR014/JCAR017 (Juno Therapeutics), KTE-C19 (Kite Pharma), and CTL019 (tisagenlecluecel-T)(Novartis Pharmaceuticals). These potential CAR-T therapies or their next generations e.g. armoured' CARs and humanized versions are in development.